{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:26:55Z","timestamp":1770467215995,"version":"3.49.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>With the coverage of COVID-19 vaccination, it has been possible to observe the potential side effects of SARS-CoV-2 vaccines, with the most common ones being fever, myalgia, headache, and fatigue. However, an association has been observed between new and recurrent kidney injuries, mainly glomerulonephritis and lupus nephritis associated with ANCA, with the Pfizer-BioNTech, Moderna, Sinovac, and AstraZeneca vaccines, although the relationship between them is\u00a0not clear. We report a case of ANCA-related vasculitis and lupus glomerulonephritis after the second dose of the AstraZeneca vaccine. The elderly patient presented significant worsening of kidney function after immunosuppression and complications after a new onset COVID-19 infection that led to death. We provide a literature review about kidney damage related to ANCA vasculitis after COVID-19 vaccine, aiming for a better understanding of the pathophysiological mechanism of kidney injury, its presentation, and treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1298622","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T06:32:30Z","timestamp":1704695550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Marcos Adriano Garcia","family":"Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago de Oliveira","family":"Valois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Eduardo","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Fernandes","family":"Vasques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Goulart","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Maria do Nascimento","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalino","family":"Salgado Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Moraes da Rocha","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Precil Diego Miranda de Menezes","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyl Eanes Barros","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.34172\/npj.2022.01","article-title":"Kidney complications following COVID-19 vaccination; a review of the literature","volume":"11","author":"Hassanzadeh","year":"2021","journal-title":"J Nephropharmacol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.002","article-title":"COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation","volume":"100","author":"Li","year":"2021","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.06.027","article-title":"Review of early immune response to SARS-CoV-2 vaccination among patients with CKD","volume":"6","author":"Carr","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.956158","article-title":"Kidney injury associated with COVID-19 infection and vaccine: A narrative review","volume":"9","author":"Pacheco","year":"2022","journal-title":"Front Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.584235","article-title":"Brazilian consortium for the study on renal diseases associated with COVID-19: A multicentric effort to understand SARS-CoV-2-related nephropathy","volume":"7","author":"Teixeira J\u00fanior","year":"2020","journal-title":"Front Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.270254","article-title":"Vaccine-associated kidney diseases: A narrative review of the literature","volume":"30","author":"Patel","year":"2019","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"B7","article-title":"Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination","volume":"54","author":"Kielstein","year":"2000","journal-title":"Clin Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.97893","article-title":"Can influenza H1N1 vaccination lead to the membranous glomerulonephritis","volume":"55","author":"Kutlucan","year":"2012","journal-title":"Indian J Pathol Microbiol"},{"key":"B9","article-title":"Vaccines and autoimmune diseases of the adult","volume":"9","author":"Orbach","year":"2010","journal-title":"Discovery Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.892","article-title":"Microscopic polyangiitis after influenza vaccination","volume":"44","author":"Uji","year":"2005","journal-title":"Intern Med Tokyo Jpn"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.5.740","article-title":"Influenza vaccine\u2013a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate","volume":"15","author":"Plotkin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"B12","article-title":"[Necrotizing glomerulonephritis in decursu vasculitis after vaccination against influenza]","volume":"19","author":"Hyla-Klekot","year":"2005","journal-title":"Pol Merkur Lek Organ Pol Tow Lek"},{"key":"B13","article-title":"HENOCH-SCH\u00d6NLEIN PURPURA NEPHRITIS FOLLOWING INFLUENZA VACCINATION: A CASE REPORT AND REVIEW OF THE LITERATURE","volume":"47","author":"Liu","year":"2016","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.242.23.2555","article-title":"Progression of renal disease in Henoch-Sch\u00f6nlein purpura after influenza vaccination","volume":"242","author":"Damjanov","year":"1979","journal-title":"JAMA"},{"key":"B15","first-page":"349","article-title":"Nephrotic syndrome after recombinant hepatitis B vaccine","volume":"43","author":"Mac\u00e1rio","year":"1995","journal-title":"Clin Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5414\/cnp67061","article-title":"Lupus nephritis after hepatitis B vaccination: an uncommon complication","volume":"67","author":"Santoro","year":"2007","journal-title":"Clin Nephrol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/bmj.306.6872.248-b","article-title":"Vaccine related glomerulonephritis","volume":"306","author":"Tan","year":"1993","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-10-21","article-title":"Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination","volume":"10","author":"Clajus","year":"2009","journal-title":"BMC Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05835-4","article-title":"Vaccines and nephrotic syndrome: efficacy and safety","volume":"38","author":"Angeletti","year":"2022","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5841.665-a","article-title":"Measles vaccination and the nephrotic syndrome","volume":"4","author":"Kuzemko","year":"1972","journal-title":"Br Med J"},{"key":"B21","article-title":"Case report: glomerulonephritis after immunization with antirabies vaccine","volume":"46","author":"Singhal","year":"1981","journal-title":"Ann Allergy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12894-017-0304-5","article-title":"Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer","volume":"17","author":"Mohammed","year":"2017","journal-title":"BMC Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050983","article-title":"ANCA associated glomerulonephritis following SARS-CoV-2 vaccination: A case series and systematic review","volume":"11","author":"Thammathiwat","year":"2023","journal-title":"Vaccines"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25100","article-title":"Longitudinal patterns of renal function in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"75","author":"Hanberg","year":"2023","journal-title":"Arthritis Care Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2023.0031","article-title":"Recovery and long-term renal outcome of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis who are on dialysis at presentation","volume":"30","author":"Lee","year":"2023","journal-title":"J Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.016","article-title":"De novo vasculitis after mRNA-1273 (Moderna) vaccination","volume":"100","author":"Anderegg","year":"2021","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.08.012","article-title":"Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis following the Pfizer-BioNTech COVID-19 vaccine","volume":"6","author":"Dube","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765447","article-title":"Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage may occur after COVID-19 vaccination","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8400842","article-title":"De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis","volume":"2021","author":"Davidovic","year":"2021","journal-title":"Case Rep Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19616","article-title":"De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19","volume":"13","author":"Feghali","year":"2021","journal-title":"Cureus"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.762006","article-title":"Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination","volume":"12","author":"Hakroush","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5414\/CN110794","article-title":"De novo or recurrent glomerulonephritis and acute tubulointerstitial nephritis after COVID-19 vaccination: A report of six cases from a single center","volume":"97","author":"Schaubschlager","year":"2022","journal-title":"Clin Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.07.026","article-title":"A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality","volume":"100","author":"Villa","year":"2021","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13993","article-title":"Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients","volume":"27","author":"David","year":"2022","journal-title":"Nephrol Carlton Vic"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11397","article-title":"Clinical Images: Severe proteinase 3 antineutrophil cytoplasmic antibody glomerulonephritis temporally associated with Sinovac Biotech\u2019s inactivated SARS-CoV-2 vaccine","volume":"4","author":"Garcia","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000525562","article-title":"ANCA-associated vasculitis following the first dose of Pfizer-BioNTech COVID-19 vaccine","volume":"147","author":"El Hasbani","year":"2023","journal-title":"Nephron"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e204","article-title":"A case report of MPO-ANCA-associated vasculitis following heterologous mRNA1273 COVID-19 booster vaccination","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30565","article-title":"Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis as a possible side effect of COVID-19 vaccination","volume":"14","author":"Noel","year":"2022","journal-title":"Cureus"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab181","article-title":"MPO-ANCA-associated vasculitis after the Pfizer\/BioNTech SARS-CoV-2 vaccination","volume":"15","author":"Obata","year":"2021","journal-title":"Clin Kidney J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05069-x","article-title":"ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review","volume":"42","author":"Prabhahar","year":"2022","journal-title":"Rheumatol Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly-127124","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis in a 15-year-old patient after receiving the second dose of the BBIBP-CorV (Sinopharm) COVID-19 vaccine: A case report","volume":"14","author":"Ramezanzade","year":"2022","journal-title":"Nephro-Urol Mon"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e154","article-title":"Microscopic polyangiitis following mRNA COVID-19 vaccination: A case report","volume":"37","author":"So","year":"2022","journal-title":"J Korean Med Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9807-22","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis after COVID-19 vaccination with Pfizer-BioNTech","volume":"61","author":"Suzuki","year":"2022","journal-title":"Intern Med Tokyo Jpn"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104123","article-title":"ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine","volume":"79","author":"Yadav","year":"2022","journal-title":"Ann Med Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1003332","article-title":"ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: Is there a causal relationship? A case report","volume":"9","author":"Zamoner","year":"2022","journal-title":"Front Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0005372021","article-title":"Glomerular disease in temporal association with SARS-CoV-2 vaccination: A series of 29 cases","volume":"2","author":"Caza","year":"2021","journal-title":"Kidney360"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.ijn_352_21","article-title":"Post COVID vaccination (COVAXINTM -BB152 V) pauci-immune crescentic glomerulonephritis","volume":"32","author":"Bansal","year":"2022","journal-title":"Indian J Nephrol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.07.019","article-title":"Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine","volume":"100","author":"Tuschen","year":"2021","journal-title":"Kidney Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab284","article-title":"Lupus nephritis flare post Moderna mRNA-1273 coronavirus vaccine","volume":"114","author":"Sekar","year":"2022","journal-title":"QJM Mon J Assoc Physicians"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.009","article-title":"New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination","volume":"100","author":"Zavala-Miranda","year":"2021","journal-title":"Kidney Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.01.013","article-title":"New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination","volume":"101","author":"Kim","year":"2022","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13995","article-title":"Report of two cases of minimal change disease following vaccination for COVID -19","volume":"27","author":"Baskaran","year":"2022","journal-title":"Nephrol Carlton Vic"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2021.09.003","article-title":"Glomerulopathies after vaccination against COVID-19. Four cases with three different vaccines in Argentina","volume":"43","author":"Fern\u00e1ndez","year":"2021","journal-title":"Nefrol Publicacion Of Soc Espanola Nefrol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.06.032","article-title":"IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine","volume":"100","author":"Hanna","year":"2021","journal-title":"Kidney Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab215","article-title":"Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial","volume":"36","author":"Izzedine","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.06.011","article-title":"Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy","volume":"100","author":"Kudose","year":"2021","journal-title":"Kidney Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13992","article-title":"Gross haematuria after mRNA COVID-19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy","volume":"27","author":"Lo","year":"2022","journal-title":"Nephrol Carlton Vic"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-021-00677-9","article-title":"New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report","volume":"11","author":"Nakatani","year":"2022","journal-title":"CEN Case Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231153217","article-title":"Double-Positive Anti\u2013Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody\u2013Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients","volume":"10","author":"Ting","year":"2023","journal-title":"Can J Kidney Health Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-022-00695-1","article-title":"Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review","volume":"11","author":"Sugita","year":"2022","journal-title":"CEN Case Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.009","article-title":"Is COVID-19 vaccination unmasking glomerulonephritis","volume":"100","author":"Tan","year":"2021","journal-title":"Kidney Int"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1159\/000525737","article-title":"Anti-GBM Disease after Oxford-AstraZeneca ChAdOx1 nCoV-19 Vaccination: A Report of Two Cases","volume":"12","author":"Coorey","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13730-023-00792-9","article-title":"A case of rapidly progressive glomerulonephritis with double-positive anti-GBM antibody and MPO-ANCA after SARS-CoV-2 vaccination and relapse during 1 year follow-up","volume":"27","author":"Terakawa","year":"2023","journal-title":"CEN Case Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.06.006","article-title":"Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination","volume":"100","author":"Sacker","year":"2021","journal-title":"Kidney Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.10.020","article-title":"Concurrent antiglomerular basement membrane nephritis and antineutrophil cytoplasmic autoantibody-mediated glomerulonephritis after second dose of SARS-CoV-2 mRNA vaccination","volume":"7","author":"Gupta","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.33160\/yam.2023.05.008","article-title":"Atypical anti-glomerular basement membrane nephritis after the first dose of the severe acute respiratory syndrome coronavirus 2 mRNA vaccine","volume":"66","author":"Hoi","year":"2023","journal-title":"Yonago Acta Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.001","article-title":"Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination","volume":"100","author":"Ayd\u0131n","year":"2021","journal-title":"Kidney Int"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-021-00646-2","article-title":"A case of anti-GBM nephritis following centipede bites and COVID-19 vaccination","volume":"11","author":"Nagai","year":"2022","journal-title":"CEN Case Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00467-022-05681-4","article-title":"A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination","volume":"38","author":"Kim","year":"2023","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.03.010","article-title":"Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Lebedev","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108665","article-title":"Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u201cpotential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\u201d","volume":"224","author":"Talotta","year":"2021","journal-title":"Clin Immunol Orlando Fla"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.934399","article-title":"Myocarditis, pulmonary hemorrhage, and extensive myositis with rhabdomyolysis 12 days after first dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: A case report","volume":"23","author":"Al-Rasbi","year":"2022","journal-title":"Am J Case Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020298","article-title":"Spectrum of kidney injury following COVID-19 disease: renal biopsy findings in a single Italian pathology service","volume":"12","author":"Gambella","year":"2022","journal-title":"Biomolecules"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab252","article-title":"Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality","volume":"15","author":"Psyllaki","year":"2022","journal-title":"Clin Kidney J"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcac094","article-title":"Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine","volume":"115","author":"Park","year":"2022","journal-title":"QJM Mon J Assoc Physicians"},{"key":"B79","first-page":"2022","article-title":"Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation","volume":"39","author":"Annicchiarico Petruzzelli","year":"2022","journal-title":"G Ital Nefrol Organo Uff Della Soc Ital Nefrol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.04.035","article-title":"Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine","volume":"100","author":"D\u2019Agati","year":"2021","journal-title":"Kidney Int"},{"key":"B81","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1053\/j.ajkd.2021.05.003","article-title":"An additional case of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Maas","year":"2021","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.06.004","article-title":"Post-vaccinal minimal change disease","volume":"100","author":"Weijers","year":"2021","journal-title":"Kidney Int"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.04.033","article-title":"Minimal change disease relapse following SARS-CoV-2 mRNA vaccine","volume":"100","author":"Kervella","year":"2021","journal-title":"Kidney Int"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.05.006","article-title":"Relapse of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Komaba","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.kint.2021.06.005","article-title":"Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine","volume":"100","author":"Morlidge","year":"2021","journal-title":"Kidney Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.007","article-title":"Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine","volume":"100","author":"Holzworth","year":"2021","journal-title":"Kidney Int"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.12.016","article-title":"Collapsing glomerulopathy following SARS-CoV-2 adenovirus-vector-based vaccine: report of 2 cases","volume":"101","author":"Neves","year":"2022","journal-title":"Kidney Int"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.04.029","article-title":"Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy","volume":"92","author":"Turner-Stokes","year":"2017","journal-title":"Kidney Int"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04391007","article-title":"Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity","volume":"3","author":"Nasr","year":"2008","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003748","article-title":"Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis","volume":"95","author":"Jarrot","year":"2016","journal-title":"Med (Baltimore)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1298622\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T06:32:35Z","timestamp":1704695555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1298622\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":91,"alternative-id":["10.3389\/fimmu.2023.1298622"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1298622","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1298622"}}